2Danesh J,Lewington S,Thompson SG,et al.Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality:an individual participant meta-analysis[J].JAMA,2005,294:1799-1809.
3Anuurad E,Rubin J,Chiem A,et al.High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a)levels in african-americans[J].J Clin Endocrinol Metab,2008,93:1482-1488.
4Srisawasdi P,Chaloeysup S,Teerajetgul Y,et al.Estimation of plasma small dense LDL cholesterol from classic lipid measures[J].Am J Clin Pathol[J],2011,136:20-29.
6Danesh J,Wheeler JG,Hirschfield GM,et al.C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[J].N Engl J Med,2004,350:1387-1397.
7Bogavac-Stanojevic N,Jelic-Ivanovic Z,Spasojevic-Kalimanovska V,et al.Lipid and inflammatory markers for the prediction of coronary artery disease:a multi-marker approach[J].Clin Biochem,2007,40:1000-1006.
8D’Angelo A,Ruotolo G,Garancini P,et al.Lipoprotein(a),fibrinogen and vascular mortality in an elderly northern Italian population[J].Haematologica,2006,91:1613-1620.
9Paultre F,Pearson TA,Weil HF,et al.High levels of Lp(a)with a small apo(a)isoform are associated with coronary artery disease in African American and white men[J].Arterioscler ThrombVasc Biol,2000,20:2619-2624.
10Turner RC,Millns H,Neil HA,et al.Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus:United Kingdom Prospective Diabetes Study(UKPDS:23)[J].BMJ,1998,316:823-828.
10World Health Organization. Definition, diagnosis and classifications of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.
